Challenge: expanding access to hepatitis B care and treatment.





Effective, low-cost antiviral medications can treat hepatitis B, cutting liver cancer risk in half. However, of the estimated 254 million people with hepatitis B, only 13% are diagnosed and a scant number receive treatment.

The World Health Organization (WHO) recently simplified treatment criteria, increasing eligibility for treatment by non-liver specialists. To improve the health of people with hepatitis B in low- and middle-income countries, the recently launched Center for Operational Research on Hepatitis B is seeking to develop pathways of simplified care and integrated service delivery.





Comments

Popular posts from this blog

Let’s Break It Down.

Global Webinar to mark the World Hepatitis Day 2025.

World Hepatitis Day 2025 Launch Event.